Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Carcinoma, Hepatocellular 6Liver Neoplasms 5Neoplasm Metastasis 3Biliary Tract Neoplasms 2Squamous Intraepithelial Lesions 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pain 1Osteosarcoma 1Lung Neoplasms 1Hepatitis B, Chronic 1HIV-negative Subjects With Intra-anal Intraepithelial Neoplasia Containing High-Grade Squamous Intraepithelial Lesions 1Esophageal Squamous Cell Neoplasia (ESCN) 1Esophageal Squamous Cell Carcinoma 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Bile Duct Neoplasms 1Barrett Esophagus 1Adrenal Gland Neoplasms 1Adenocarcinoma of Lung 1Adenocarcinoma 1

Interventions

pertuzumab 1Surgical Procedures, Operative 1Radiosurgery 1Radiofrequency Ablation 1Observation 1Erlotinib Hydrochloride 1Adrenalectomy 1(18F)GTP1 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Adrenal Gland Neoplasms × Radiofrequency Ablation × Clear all
NCT00997594 2015-04-28

Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation

Mie University

Phase 2/3 Completed
18 enrolled 6 charts
Endocrine

Adrenal Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡